News
Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?
Once upon a time, Gilead Sciences (NASDAQ: GILD) was one of the hottest biotech stocks on the market. But for most of the last two years, Gilead was anything but hot, with its market cap losing....
Why Abeona Therapeutics Inc. (and Maybe Sangamo Therapeutics, Inc.) Jumped Higher Today
Shares of Abeona Therapeutics (NASDAQ: ABEO) jumped 18.4% on Tuesday, while shares of Sangamo Therapeutics (NASDAQ: SGMO) ended up 11.3%. The former is clearly because Abeona received a....
Here's Why AVEO Pharmaceuticals Lost as Much as 19% Today
Shares of biopharma AVEO Pharmaceuticals (NASDAQ: AVEO) sank 19% Tuesday after investors had more time to digest Monday's news. That was, the company announced that the drug Fotivda gained....
Why Movado Group, Catalent, and ImmunoGen Jumped Today
The stock market slowly climbed over the course of Tuesday's session as geopolitical events and the continuing aftermath of Hurricane Harvey dominated headlines. Investors were initially rattled....
This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier
If you're one of the millions of Americans diagnosed with diabetes, large pharmacy benefits manager (PBM) Express Scripts (NASDAQ: ESRX) has good news for you. There's something you can do that....
Why Acorda Therapeutics Is Losing One-Quarter of Its Value Today
After reporting that it has received a refuse-to-file letter from the FDA regarding its Parkinson's disease drug, Inbrija, shares in Acorda Therapeutics (NASDAQ: ACOR) are crashing 25% at 12:30....
Why Juno Therapeutics Stock Is Blasting Off Today
Shares of Juno Therapeutics (NASDAQ: JUNO) are up by double digits for the second day in a row on extremely heavy volume. The catalyst behind this continued surge higher is the nearly $12 billion....
Why ImmunoGen, Inc. Jumped Higher Today
Shares of ImmunoGen (NASDAQ: IMGN) are up 17.5% at 12:50 p.m. EDT after the company announced an option deal with Jazz Pharmaceuticals (NASDAQ: JAZZ) for three antibody-drug conjugate (ADC) drugs....
Why Catalent Inc. Rose as Much as 17% This Morning
Shares of drug-delivery technology specialist Catalent (NYSE: CTLT) jumped as much as 17% Tuesday morning in the wake of the company's 2017 fiscal year earnings report, released Monday after the....
Can Gilead Sciences Squeeze $12 Billion From Kite Pharma?
Gilead Sciences, Inc. (NASDAQ: GILD) just took a bold leap into the unknown with an agreement to acquire Kite Pharma Inc. (NASDAQ: KITE) for $180 per share or about $11.9 billion. Gilead's last....
These 3 Stocks Look Expensive but Are Actually Cheap
A stock's price -- or even its current valuation -- rarely tell the whole story regarding its ability to produce respectable returns on capital over the long-term. In fact, deep value can be....
Is Inovio Pharmaceuticals Stock Poised for a Rebound?
2017 was shaping up to be a good year for Inovio Pharmaceuticals (NASDAQ: INO). The stock was up more than 15% halfway through the year. And then shareholders got the bad news.In July, Inovio....
3 Healthcare Stocks to Buy With Dividends Yielding More Than 3%
There are fewer healthcare stocks with high yields than you might think. At least that's the case depending on your definition of "healthcare stocks" and "high yields." If you think a high-yield....
Here's What Else Gilead Sciences Gets by Buying Kite Pharma
Gilead Sciences' (NASDAQ: GILD) planned $11.9 billion acquisition of Kite Pharma (NASDAQ: KITE) nets it axi-cel, a CAR-T therapy that's already under FDA review. However, axi-cel isn't the only
Get Ready for More Acquisitions by Gilead Sciences
Investors woke up Monday morning to a pleasant surprise from Gilead Sciences (NASDAQ: GILD). The big biotech announced plans to acquire Kite Pharma (NASDAQ: KITE) for $11.9 billion. The market....
We Got It Wrong With OPKO Health -- Now What?
In our "These Legendary CEO's Could Catch Lightning in a Bottle – Again" episode, Motley Fool Industry Focus: Healthcare contributor Todd Campbell picked OOKO Health (NASDAQ: OPK) as a stock to....
Why Thor Industries, IXYS Corporation, and Kite Pharma Jumped Today
Activity on the stock market was muted today as investors focused on the damage left by Hurricane Harvey. The major benchmarks showed mixed results, but stayed close to where they started the day.....
Here's Why Immunomedics Rose as Much as 14.2% Today
Shares of preclinical biopharma Immunomedics (NASDAQ: IMMU) gained over 14% today without any company-specific news. However, earlier in the day, the nearly $12 billion buyout of Kite Pharma by....
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
bluebird bio (NASDAQ: BLUE) is up 9.5% and Juno Therapeutics (NASDAQ: JUNO) is up 17% at 12:40 p.m. EDT Monday. Both appear to be riding the coattails of fellow immuno-oncology drug developer Kite....
Gilead's Plan? Cash In on CAR-T
Investors eagerly awaiting news of how Gilead Sciences' (NASDAQ: GILD) plans to spend its growing mountain of cash found out on Monday that the company's plans to become a leader in cancer....
Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle?
Gilead Sciences (NASDAQ: GILD), prompted by its falling sales of its hepatitis C drugs over the past year, has finally pulled the trigger on a much-anticipated buyout: On Monday, it offered to....
3 Reasons to Applaud Gilead Sciences' Acquisition of Kite Pharma
Finally.Gilead Sciences (NASDAQ: GILD) announced on Monday that it was acquiring Kite Pharma (NASDAQ: KITE) for $11.9 billion. Investors had long waited for the big biotech to make a deal. One....
In Your 60s? 3 Stocks You Might Want to Buy
For many Americans, reaching their 60s is often the point where they transition out of the labor force and into retirement. It means putting that alarm clock to bed for good and putting your feet....
Can Buying Exelixis Stock Still Make You Rich?
What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.But there were some investors who did something on that date who probably recall it with a smile.....
Why I Love AbbVie Inc.
"Where your treasure is, there will your heart be also."Those profound words were spoken nearly 2,000 years ago. They were true then, and they're still true today. But even when your treasure is....